KOVAI MEDICAL CENTER & HO Fair Value

KOVAI · Healthcare · Current price ₹5,969

Full stock page
DocStoX fair value
₹3,202
medium confidence · 62/100
Current price
₹6,204
Upside to fair value
-48.4%
Estimate range
₹2,882 – ₹3,523
Quality score
6.3 / 10
Model it yourself — Margin of Safety Calculator
Opens pre-filled with KOVAI MEDICAL CENTER & HO's latest numbers.

Is KOVAI MEDICAL CENTER & HO undervalued?

We estimate the fair value of KOVAI MEDICAL CENTER & HO at ₹3,202 per share, against a market price of ₹6,204. That puts the share price about -48.4% above our estimate, at medium confidence. This is our view of what the business is worth, not a target price or a forecast of where the share price will go.

How this fair value is calculated

This estimate comes from 1 method: Discounted cash flow (2-stage) (₹3,202). Each is weighted by how well its inputs held up for this company. The full working, including the assumptions and what data was missing, is set out below.

The range around this estimate

Our estimate for KOVAI MEDICAL CENTER & HO spans ₹2,882 to ₹3,523. A margin of safety means buying meaningfully below the estimate: the wider the range, the more room the assumptions leave for error.

How we got this fair value

Every number below is part of the same estimate for KOVAI MEDICAL CENTER & HO. Nothing here is a target price or a forecast of where the share price will go.

Medium confidence62/100

Workable, with real gaps. Weigh it alongside your own view rather than on its own.

Estimate range ₹2,882 – ₹3,523

Why this method for this business

The DCF model is appropriate for a healthcare provider with stable cash flows and a long-term growth trajectory. EV/EBITDA is suitable for valuing a capital-light business with predictable margins.

The models behind the number

Each method is weighted by how well its inputs held up for this company.

Discounted cash flow (2-stage)
₹3,20270% weight

Intrinsic value from 2-stage discounted cash flows (primary for asset-light / normal businesses); FCFE path

EV / EBITDA(not enough data)

required inputs missing

  • Relative PE is not used due to lack of comparable peers
  • FCF-based models are not used due to limited forward data

What was missing

  • Forward estimates are not available
  • Limited peer data for EV/EBITDA normalization

What drives it

12 inputs, grouped by how strong each claim is
ReportedRead from filings or market data. Verifiable, not our opinion.
FCF_0 (normalized)
136 ₹cr

fcf_norm (median ≤5y positive)

Net debt
402.8 ₹cr

gross debt (cash n/a)

MacroEconomy-wide input, not company-specific.
Discount rate (r)
13.28%

COE (building-block)

Beta
0.85

bottom-up industry

AssumptionA forward input the model chose. Reasonable people can disagree here.
Stage-1 start growth
20%

pat_cagr_5y

Fade shape
linear

lifecycle Growth

Terminal growth (g)
5.41%

macro terminal × quality premium

Stage-1 years
10 y

lifecycle Growth horizon

JudgementOur read of the evidence, not a measurement.
Lifecycle stage
Growth

forecast engine (L20)

Quality premium
1.081×

moat Narrow + capital allocation

DerivedFalls out of the inputs above: a model output, not an independent input.
Path
FCFE

computed (D/E vs 0.8)

Terminal-value fraction
0.536

PV_TV / (PV_1+PV_TV)

Who computed this

A language model (qwen3:8b) selects the valuation method and the judgement inputs for KOVAI MEDICAL CENTER & HO: which models suit the business, the moat, the growth and margin assumptions. It does not produce the number. The fair value itself is computed in Python by a deterministic engine (version 2026.08.1) from those inputs, so the same inputs always give the same result and every figure above can be traced to a source.

Estimated 14 Sept 2026. Re-run as new financials and news arrive.

How we value stocks

We estimate what a business is worth from its own economics: cash flows, returns on capital, and a multiple justified by its quality, rather than from where the share price has been. A fair value estimate is a view, not a verdict, and it is only as good as the inputs listed above.

Read the full fair-value methodology

More on KOVAI MEDICAL CENTER & HO

DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.